Europe has historically been at the forefront of innovation in life sciences. Next-generation therapies and the rise of digital health have created new opportunities for business, but global shifts in the competitive landscape and the prospect of major regulatory reform also present challenges.
Nathalie Moll, EFPIA Director General, and Jacky Vonderscher, CEO of ENYO Pharma, joined the 2023 FT Global Pharma and Biotech Summit to discuss the opportunities for both big pharma companies and SMEs operating in Europe, considering the upcoming legislative changes.
How could health systems change to support access to innovative treatments?
What challenges exist for pharma companies operating in Europe around security of supply?
Watch the event recording.
Other sessions from the "FT Global Pharma and Biotech Summit" can be watched here: pharma.live.ft...
15 ноя 2023
